title: Optimizing the Benefit of CNS Radiation Therapy in the Pediatric Population-PART 1: Understanding and Managing Acute and Late Toxicities.
abstract: Radiation therapy continues to be a key component in the management of pediatric malignancies. Increasing the likelihood of cure while minimizing late treatment toxicity in these young patients remains the primary goal. Within the realm of central nervous system neoplasms, efforts to further improve the efficacy of radiation therapy continue, while balancing risks of damage to uninvolved tissue. Radiation therapy can result in second malignancies, as well as cerebrovascular, neurotoxic, neurocognitive, endocrine, psychosocial, and quality-of-life effects. In this article we describe these acute and late effects and their implications, and we highlight strategies that have emerged to reduce both the volume of tissue that is irradiated and the radiation dose delivered. The feasibility, efficacy, and risks of these newer approaches to radiation therapy continue to be evaluated and monitored; robust outcome data are needed.
authors.forename: Lindsay S
authors.initials: LS
authors.lastname: Rowe
authors.forename: Andra V
authors.initials: AV
authors.lastname: Krauze
authors.forename: Holly
authors.initials: H
authors.lastname: Ning
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Camphausen
authors.forename: Aradhana
authors.initials: A
authors.lastname: Kaushal
mesh_terms: D000328:Adult; D000367:Age Factors; D016543:Central Nervous System Neoplasms / Q000175:diagnosis / Q000532:radiotherapy*; D002648:Child; D016371:Cranial Irradiation / Q000009:adverse effects*; D006801:Humans; D011788:Quality of Life; D011829:Radiation Dosage; D011832:Radiation Injuries / Q000175:diagnosis / Q000209:etiology / Q000523:psychology / Q000628:therapy*; D012307:Risk Factors; D017741:Survivors / Q000523:psychology; D013997:Time Factors; D016896:Treatment Outcome